A detailed history of Bank Of America Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 993,237 shares of REGN stock, worth $710 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
993,237
Previous 968,104 2.6%
Holding current value
$710 Million
Previous $1.02 Billion 2.62%
% of portfolio
0.09%
Previous 0.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1024.09 - $1201.76 $25.7 Million - $30.2 Million
25,133 Added 2.6%
993,237 $1.04 Billion
Q2 2024

Aug 14, 2024

BUY
$883.2 - $1071.19 $74.2 Million - $90 Million
84,036 Added 9.51%
968,104 $1.02 Billion
Q1 2024

May 15, 2024

BUY
$902.69 - $993.35 $5.1 Million - $5.62 Million
5,655 Added 0.64%
884,068 $851 Million
Q4 2023

Feb 14, 2024

BUY
$775.18 - $881.7 $30.9 Million - $35.2 Million
39,868 Added 4.75%
878,413 $772 Million
Q2 2023

Aug 14, 2023

SELL
$700.03 - $830.35 $76.2 Million - $90.4 Million
-108,865 Reduced 11.49%
838,545 $603 Million
Q1 2023

May 12, 2023

BUY
$680.49 - $826.97 $36.6 Million - $44.4 Million
53,728 Added 6.01%
947,410 $778 Million
Q4 2022

Feb 10, 2023

SELL
$705.89 - $766.39 $109 Million - $119 Million
-154,802 Reduced 14.76%
893,682 $645 Million
Q3 2022

Nov 14, 2022

SELL
$573.97 - $724.32 $7.93 Million - $10 Million
-13,820 Reduced 1.3%
1,048,484 $722 Million
Q2 2022

Aug 12, 2022

SELL
$548.35 - $738.84 $47.7 Million - $64.2 Million
-86,940 Reduced 7.56%
1,062,304 $628 Million
Q1 2022

May 16, 2022

SELL
$595.12 - $698.43 $7.18 Million - $8.43 Million
-12,070 Reduced 1.04%
1,149,244 $803 Million
Q4 2021

Feb 08, 2022

BUY
$543.48 - $670.97 $2.74 Million - $3.38 Million
5,040 Added 0.44%
1,161,314 $733 Million
Q3 2021

Nov 15, 2021

BUY
$574.03 - $680.96 $23.2 Million - $27.5 Million
40,430 Added 3.62%
1,156,274 $700 Million
Q2 2021

Sep 13, 2021

BUY
$472.8 - $558.54 $528 Million - $623 Million
1,115,844 New
1,115,844 $623 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.